← Back to Search

Radiation Therapy

FLASH Radiotherapy for Bone Metastasis (FAST-01 Trial)

N/A
Waitlist Available
Led By John Breneman, MD
Research Sponsored by Varian Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at day 15, months 1, 2, 3, long term; flare in bone pain assessed during the first 10 days after treatment
Awards & highlights

FAST-01 Trial Summary

This trial will test if FLASH radiotherapy can provide pain relief for people with bone metastases.

Eligible Conditions
  • Bone Metastasis

FAST-01 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~will be assessed within 4 weeks of subject enrollment.
This trial's timeline: 3 weeks for screening, Varies for treatment, and will be assessed within 4 weeks of subject enrollment. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Assessment of radiation-related toxicities that are possibly, probably, or definitely related to FLASH radiotherapy.
Workflow feasibility
Secondary outcome measures
Pain relief
Use of pain medication.

FAST-01 Trial Design

1Treatment groups
Experimental Treatment
Group I: FLASH radiotherapy for painful bone metastasis(-es)Experimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
FLASH Radiotherapy
2020
N/A
~10

Find a Location

Who is running the clinical trial?

Varian MedicalLead Sponsor
6 Previous Clinical Trials
320 Total Patients Enrolled
Varian, a Siemens Healthineers CompanyLead Sponsor
30 Previous Clinical Trials
7,263 Total Patients Enrolled
John Breneman, MDPrincipal InvestigatorProfessor of Radiation Oncology and Neurosurgery, UCMC
1 Previous Clinical Trials
10 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Apr 2025